Open access
Open access
Powered by Google Translator Translator

#ESCCongress – RCT: In patients who underwent PCI at high bleeding risk, 1 month of dual antiplatelet therapy was noninferior to the continuation of dual therapy for at least 2 additional months and resulted in a lower incidence of bleeding events.

29 Aug, 2021 | 18:16h | UTC

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk – New England Journal of Medicine

Commentaries:

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated vs. Standard DAPT Regimen – MASTER DAPT – American College of Cardiology

MASTER-DAPT: Abbreviated DAPT vs. Standard DAPT in High-Risk Patients Post-PCI – American College of Cardiology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.